IP vs RXST
International Paper (IP) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. RXST currently screens at market cap $198.3M.
Not investment advice. Open the IP and RXST stock pages for the full models.
Not investment advice.